U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cantor A, Dana T, Griffin JC, et al. Screening for Chlamydial and Gonococcal Infections: A Systematic Review Update for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Sep. (Evidence Synthesis, No. 206.)

Cover of Screening for Chlamydial and Gonococcal Infections: A Systematic Review Update for the U.S. Preventive Services Task Force

Screening for Chlamydial and Gonococcal Infections: A Systematic Review Update for the U.S. Preventive Services Task Force [Internet].

Show details

References

1.
U.S. Preventive Services Task Force. Screening for Chlamydia and Gonorrhea: Recommendation Statement. American Family Physician. 2015;91(7):486A–D.
2.
U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007Jul17;147(2):128–34. doi: 10.7326/0003-4819-147-2-200707170-00172. PMID: 17576996. [PubMed: 17576996] [CrossRef]
3.
U.S. Preventive Services Task Force. Screening for Gonorrhea: Recommendation Statement. Ann Fam Med. 2005;3(3):263–7. doi: 10.1370/afm.337. PMID: 15928231. [PMC free article: PMC1466867] [PubMed: 15928231] [CrossRef]
4.
StephensRS. The cellular paradigm of chlamydial pathogenesis. Trends in microbiology. 2003Jan16;11(1):44–51. doi: 10.1016/S0966-842X(02)00011-2. PMID: 12526854. [PubMed: 12526854] [CrossRef]
5.
Centers for Disease Control and Prevention. CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep. 2011Apr1;60(12):370–3. PMID: 21451447. [PubMed: 21451447]
6.
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2017. Atlanta, GA; 2018. https://www​.cdc.gov/std/stats17/default​.htm. Accessed April 29, 2020.
7.
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2011. US Department of Health and Human Services. Atlanta, GA: 2012. http://www​.cdc.gov/std/stats11/toc.htm.
8.
EdwardsJL, ApicellaMA. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev. 2004Oct19;17(4):965–81. doi: 10.1128/cmr.17.4.965-981.2004. PMID: 15489357. [PMC free article: PMC523569] [PubMed: 15489357] [CrossRef]
9.
MerzAJ, SoM. Interactions of pathogenic Neisseriae with epithelial cell membranes. Annual review of cell and developmental biology. 2000Oct14;16:423–57. doi: 10.1146/annurev.cellbio.16.1.423. PMID: 11031243. [PubMed: 11031243] [CrossRef]
10.
American Academy of Pediatrics. Prevention of Neonatal Ophthalmia. In: KimberlinDW, BradyMT, JacksonMA, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed.: American Academy of Pediatrics; 2018:1046.
11.
Centers for Disease Control and Prevention. Sexually Transmitted Disease surveillance 2019. Atlanta: U.S Department of Health and Human Services. 2021.
12.
TorroneE, PappJ, WeinstockH. Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep. 2014Sep26;63(38):834–8. PMID: 25254560. [PMC free article: PMC4584673] [PubMed: 25254560]
13.
AndrewsWW, GoldenbergRL, MercerB, et al. The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2000Sep;183(3):662–8. doi: 10.1067/mob.2000.106556. PMID: 10992190. [PubMed: 10992190] [CrossRef]
14.
KohlhoffSA, HammerschlagMR. Gonococcal and chlamydial infections in infants and children. In: HolmesK, ed Sexually Transmitted Diseases. 4th ed. New York, NY: McGraw-Hill; 2008:1613–27.
15.
BrocklehurstP. Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev. 2002Apr22(2):CD000098. doi: 10.1002/14651858.Cd000098. PMID: 12076381. [PubMed: 12076381] [CrossRef]
16.
WoodsCR. Gonococcal infections in neonates and young children. Seminars in pediatric infectious diseases. 2005Oct;16(4):258–70. doi: 10.1053/j.spid.2005.06.006. PMID: 16210106. [PubMed: 16210106] [CrossRef]
17.
CurrySJ, KristAH, OwensDK, et al. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2019Jan29;321(4):394–8. doi: 10.1001/jama.2018.21367. PMID: 30694327. [PubMed: 30694327] [CrossRef]
18.
BrunhamRC, GottliebSL, PaavonenJ. Pelvic Inflammatory Disease. New England Journal of Medicine. 2015;372(21):2039–48. doi: 10.1056/NEJMra1411426. PMID: 25992748. [PubMed: 25992748] [CrossRef]
19.
WiesenfeldHC, HillierSL, MeynLA, et al. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol. 2012Jul;120(1):37–43. doi: 10.1097/AOG.0b013e31825a6bc9. PMID: 22678036. [PubMed: 22678036] [CrossRef]
20.
FlemingDT, WasserheitJN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999Feb;75(1):3–17. doi: 10.1136/sti.75.1.3. PMID: 10448335. [PMC free article: PMC1758168] [PubMed: 10448335] [CrossRef]
21.
WallinKL, WiklundF, LuostarinenT, et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer. 2002Oct1;101(4):371–4. doi: 10.1002/ijc.10639. PMID: 12209962. [PubMed: 12209962] [CrossRef]
22.
StammWE. Chlamydia trachomatis infections of the adult. In: HolmesK, ed Sexually Transmitted Diseases. 4th ed. New York, NY: McGraw-Hill; 2008:575–606.
23.
AryaR, MannionPT, WoodcockK, et al. Incidence of genital Chlamydia trachomatis infection in the male partners attending an infertility clinic. J Obstet Gynaecol. 2005May;25(4):364–7. doi: 10.1080/01443610500118749. PMID: 16091321. [PubMed: 16091321] [CrossRef]
24.
HwangL, ShaferMA. Chlamydia trachomatis infection in adolescents. Adv. Pediatr. 2004;51:379–407. PMID: 15366781. [PubMed: 15366781]
25.
BaetenJM, OverbaughJ. Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Current HIV research. 2003Jan;1(1):69–86. doi: 10.2174/1570162033352110. PMID: 15043213. [PubMed: 15043213] [CrossRef]
26.
RottingenJA, CameronDW, GarnettGP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?Sex Transm Dis. 2001Oct;28(10):579–97. PMID: 11689757. [PubMed: 11689757]
27.
AnnanNT, SullivanAK, NoriA, et al. Rectal chlamydia--a reservoir of undiagnosed infection in men who have sex with men. Sex Transm Infect. 2009Jun;85(3):176–9. doi: 10.1136/sti.2008.031773. PMID: 19176570. [PubMed: 19176570] [CrossRef]
28.
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveilance 2012. Atlanta, GA: National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Division of STD Prevention; 2013. https://www​.cdc.gov/std​/stats/archive/Surv2012.pdf. Accessed July 8, 2014.
29.
WorkowskiKA, BachmannLH, ChanPA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021Jul23;70(4):1–187. doi: 10.15585/mmwr.rr7004a1. PMID: 34292926. [PMC free article: PMC8344968] [PubMed: 34292926] [CrossRef]
30.
Centers for Disease Control and Prevention, WorkowskiKA, BermanSM. Sexually transmitted diseases treatment guidelines, 2006. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2006;55(RR-11):1–94. PMID: 16888612. [PubMed: 16888612]
31.
Johnson JonesML, Chapin-BardalesJ, BizuneD, et al. Extragenital chlamydia and gonorrhea among community venue-attending men who have sex with men - five cities, United States, 2017. MMWR. Morbidity and mortality weekly report. 2019;68(14):321–5. doi: 10.15585/mmwr.mm6814a1. PMID: 30973847. [PMC free article: PMC6459584] [PubMed: 30973847] [CrossRef]
32.
PattonME, KiddS, LlataE, et al. Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men-STD Surveillance Network, United States, 2010-2012. Clin Infect Dis. 2014Jun;58(11):1564–70. doi: 10.1093/cid/ciu184. PMID: 24647015. [PMC free article: PMC4666527] [PubMed: 24647015] [CrossRef]
33.
DewartCM, BernsteinKT, DeGrooteNP, et al. Prevalence of rectal chlamydial and gonococcal infections: a systematic review. Sexually transmitted diseases. 2018;45(5):287–93. doi: 10.1097/OLQ.0000000000000754. PMID: 29465688. [PMC free article: PMC6737334] [PubMed: 29465688] [CrossRef]
34.
ChanPA, RobinetteA, MontgomeryM, et al. Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol. 2016;2016:5758387. doi: 10.1155/2016/5758387. PMID: 27366021. [PMC free article: PMC4913006] [PubMed: 27366021] [CrossRef]
35.
TrebachJD, ChaulkCP, PageKR, et al. Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures. Sexually Transmitted Diseases. 2015May;42(5):233–9. doi: 10.1097/OLQ.0000000000000248. PMID: 25868133. [PMC free article: PMC4672628] [PubMed: 25868133] [CrossRef]
36.
DanbyCS, CosentinoLA, RabeLK, et al. Patterns of extragenital chlamydia and gonorrhea in women and men who have sex with men reporting a history of receptive anal intercourse. Sex Transm Dis. 2016Feb;43(2):105–9. doi: 10.1097/OLQ.0000000000000384. PMID: 26766527. [PMC free article: PMC4955797] [PubMed: 26766527] [CrossRef]
37.
NewmanLM, DowellD, BernsteinK, et al. A tale of two gonorrhea epidemics: results from the STD surveillance network. Public Health Rep. 2012May-Jun;127(3):282–92. doi: 10.1177/003335491212700308. PMID: 22547859. [PMC free article: PMC3314072] [PubMed: 22547859] [CrossRef]
38.
BernsteinKT, Marcus Jl Fau - NieriG, Nieri G Fau - PhilipSS, et al. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. (1944-7884 (Electronic)). [PubMed: 19935075]
39.
LlataE, BraxtonJ, AsbelL, et al. New human immunodeficiency virus diagnoses among men who have sex with men attending sexually transmitted disease clinics, STD Surveillance Network, January 2010 to June 2013. Sexually Transmitted Diseases. 2018Sep;45(9):577–82. doi: 10.1097/OLQ.0000000000000802. PMID: 29465646. [PMC free article: PMC6745693] [PubMed: 29465646] [CrossRef]
40.
BarrowRY, AhmedF, BolanGA, et al. Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2020;68(5):1–20. doi: 10.15585/mmwr.rr6805a1. PMID: 31899459. [PMC free article: PMC6950496] [PubMed: 31899459] [CrossRef]
41.
KongFY, TabriziSN, LawM, et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014Jul15;59(2):193–205. doi: 10.1093/cid/ciu220. PMID: 24729507. [PubMed: 24729507] [CrossRef]
42.
St CyrS, BarbeeL, WorkowskiKA, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep. 2020Dec18;69(50):1911–6. doi: 10.15585/mmwr.mm6950a6. PMID: 33332296. [PMC free article: PMC7745960] [PubMed: 33332296] [CrossRef]
43.
U.S. Food and Drug Administration. FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea. 2019. https://www​.fda.gov/news-events​/press-announcements​/fda-clears-first-diagnostic-tests-extragenital-testing-chlamydia-and-gonorrhea. Accessed April 30, 2020.
44.
Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep. 2014Mar14;63(RR-02):1–19. PMID: 24622331. [PMC free article: PMC4047970] [PubMed: 24622331]
45.
OlshenE, ShrierLA. Diagnostic tests for chlamydial and gonorrheal infections. Seminars in pediatric infectious diseases. 2005Jul27;16(3):192–8. doi: 10.1053/j.spid.2005.04.008. PMID: 16044393. [PubMed: 16044393] [CrossRef]
46.
LeFevreML. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014Dec16;161(12):902–10. doi: 10.7326/m14-1981. PMID: 25243785. [PubMed: 25243785] [CrossRef]
47.
PappJ, SchachterJ, GaydosC, et al. Recommendations for the Laboratory-Based Detection of Chlamydia trachomatis and Neisseria gonorrhoeae — 2014. Morbidity and Mortality Weekly Report. Atlanta, GA: 2014. https://www​.cdc.gov/std​/laboratory/2014labrec/2014-lab-rec​.pdf. [PMC free article: PMC4047970] [PubMed: 24622331]
48.
49.
MoyerCS. STDs increasing among young women; more prevention urged. American Medical News; December2009. http://www​.amednews.com​/article/20091207​/profession/312079972/6/. Accessed Dec 5, 2012.
50.
American Academy of Pediatrics. Adolescent Sexual Health: STI Screening Guidelines. https://www​.aap.org/en-us​/advocacy-and-policy​/aap-health-initiatives​/adolescent-sexual-health​/Pages/STI-Screening-Guidelines.aspx. Accessed October 18, 2018.
51.
LeeKC, Ngo-MetzgerQ, WolffT, et al. Sexually transmitted infections: recommendations from the U.S. Preventive Services Task Force. Am Fam Physician. 2016Dec1;94(11):907–15. PMID: 27929270. [PubMed: 27929270]
52.
American College of Physicians. Chlamydia Screening in Women. 2015. https://www​.acponline​.org/clinical-information​/performance-measures​/chlamydia-screening-in-women. Accessed October 15, 2020.
53.
Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections: Summary of Recommendations for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Syphilis. 2019. https://www​.canada.ca​/en/services/health​/publications/diseases-conditions​/guidelines-sti-recommendations-chlamydia-trachomatis-neisseria-gonorrhoeae-syphilis-2019.html. Accessed January 4, 2021.
54.
55.
Public Health Agency of Canada. Section 6-4: Canadian Guidelines on Sexually Transmitted Infections – Specific populations – Pregnancy. 2017. https://www​.canada.ca​/en/public-health/services​/infectious-diseases​/sexual-health-sexually-transmitted-infections​/canadian-guidelines​/sexually-transmitted-infections​/canadian-guidelines-sexually-transmitted-infections-41.html. Accessed January 4, 2021.
56.
TaoG, IrwinKL. Receipt of HIV and STD testing services during routine general medical or gynecological examinations: variations by patient sexual risk behaviors. Sex Transm Dis. 2008Feb;35(2):167–71. doi: 10.1097/OLQ.0b013e3181585be5. PMID: 18090177. [PubMed: 18090177] [CrossRef]
57.
US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. Rockville, MD: Agency for Healthcare Research and Quality; 2015. https://www​.uspreventiveservicestaskforce​.org/Page/Name/procedure-manual.
58.
NelsonHD, ZakherB, CantorA, et al. Screening for Gonorrhea and Chlamydia: Systematic Review to Update the U.S. Preventive Services Task Force Recommendations. Evidence Synthesis No. 115. AHRQ Publication No. 13-05184-EF-1. Agency for Healthcare Research and Quality (US). Rockville, MD: Quality AfHRa; September2014. PMID: 25356451. [PubMed: 25356451]
59.
MayerD. Essential Evidence-Based Medicine. 2nd ed. Cambridge, UK: Cambridge University Press; 2010.
60.
ZakherB, CantorAG, PappasM, et al. Screening for gonorrhea and Chlamydia: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2014Dec16;161(12):884–93. doi: 10.7326/M14-1022. PMID: 25244000. [PubMed: 25244000] [CrossRef]
61.
BerryL, StanleyB. Comparison of self-collected meatal swabs with urine specimens for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men. Journal of Medical Microbiology. 2017Feb;66(2):134–6. doi: 10.1099/jmm.0.000428. PMID: 28068218. [PubMed: 28068218] [CrossRef]
62.
FalasinnuT, GilbertM, GustafsonP, et al. Deriving and validating a risk estimation tool for screening asymptomatic chlamydia and gonorrhea. Sex Transm Dis. 2014Dec;41(12):706–12. doi: 10.1097/OLQ.0000000000000205. PMID: 25581805. [PubMed: 25581805] [CrossRef]
63.
FalasinnuT, GilbertM, GustafsonP, et al. A validation study of a clinical prediction rule for screening asymptomatic chlamydia and gonorrhoea infections among heterosexuals in British Columbia. Sex Transm Infect. 2016a Feb;92(1):12–8. doi: 10.1136/sextrans-2014-051992. PMID: 25933609. [PubMed: 25933609] [CrossRef]
64.
FalasinnuT, GilbertM, GustafsonP, et al. An assessment of population-based screening guidelines versus clinical prediction rules for chlamydia and gonorrhea case finding. Prev Med. 2016b Aug;89:51–6. doi: 10.1016/j.ypmed.2016.04.001. PMID: 27143496. [PubMed: 27143496] [CrossRef]
65.
FangJ, HusmanC, DeSilvaL, et al. Evaluation of self-collected vaginal swab, first void urine, and endocervical swab specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent females. J Pediatr Adolesc Gynecol. 2008;21(6):355–60. doi: 10.1016/j.jpag.2008.03.010. PMID: 19064231. [PMC free article: PMC2653455] [PubMed: 19064231] [CrossRef]
66.
GrentzerJM, PeipertJF, ZhaoQ, et al. Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion. Contracept. 2015Oct;92(4):313–8. doi: 10.1016/j.contraception.2015.06.012. PMID: 26093189. [PMC free article: PMC4575889] [PubMed: 26093189] [CrossRef]
67.
HockingJS, Temple-SmithM, GuyR, et al. Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial. Lancet. 2018Oct20;392(10156):1413–22. doi: 10.1016/S0140-6736(18)31816-6. PMID: 30343857. [PubMed: 30343857] [CrossRef]
68.
JavanbakhtM, WestmorelandD, GorbachP. Factors associated with pharyngeal gonorrhea in young people: implications for prevention. Sex Transm Dis. 2018Sep;45(9):588–93. doi: 10.1097/OLQ.0000000000000822. PMID: 29485543. [PMC free article: PMC6086760] [PubMed: 29485543] [CrossRef]
69.
LavoueV, MorcelK, VoltzenlogelMC, et al. Scoring system avoids Chlamydia trachomatis overscreening in women seeking surgical abortions. Sex Transm Dis. 2014Aug;41(8):470–4. doi: 10.1097/OLQ.0000000000000153. PMID: 25013973. [PubMed: 25013973] [CrossRef]
70.
MillerWC, HoffmanIF, Owen-O’DowdJ, et al. Selective screening for chlamydial infection: which criteria to use?Am J Prev Med. 2000Feb;18(2):115–22. doi: 10.1016/s0749-3797(99)00146-4. PMID: 10698241. [PubMed: 10698241] [CrossRef]
71.
NyeMB, OsieckiJ, LewinskiM, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae with the cobas CT/NG v2.0 test: performance compared with the BD probetec CT Q and GC Q amplified DNA and aptima AC2 assays. Sex Transm Infect. 201903;95(2):87–93. doi: 10.1136/sextrans-2018-053545. PMID: 30126947. [PMC free article: PMC6580769] [PubMed: 30126947] [CrossRef]
72.
SkidmoreS, KayeM, BaylissD, et al. Validation of COBAS Taqman CT for the detection of Chlamydia trachomatis in vulvo-vaginal swabs. Sex Transm Infect. 2008Aug;84(4):277–8; discussion 8-9. doi: 10.1136/sti.2007.029587. PMID: 18305120. [PubMed: 18305120] [CrossRef]
73.
SultanB, WhiteJA, FishR, et al. The “3 in 1” study: pooling self-taken pharyngeal, urethral, and rectal samples into a single sample for analysis for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in men who have sex with men. J Clin Microbiol. 2016Mar;54(3):650–6. doi: 10.1128/JCM.02460-15. PMID: 26719439. [PMC free article: PMC4767962] [PubMed: 26719439] [CrossRef]
74.
OakeshottP, KerryS, AghaizuA, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010Apr8;340:c1642. doi: 10.1136/bmj.c1642. PMID: 20378636. [PMC free article: PMC2851939] [PubMed: 20378636] [CrossRef]
75.
ØstergaardL, AndersenB, MollerJK, et al. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis. 2000Oct;31(4):951–7. doi: 10.1086/318139. PMID: 11049776. [PubMed: 11049776] [CrossRef]
76.
SchachterJ, McCormackWM, CherneskyMA, et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol. 2003Aug;41(8):3784–9. doi: 10.1128/jcm.41.8.3784-3789.2003. PMID: 12904390. [PMC free article: PMC179798] [PubMed: 12904390] [CrossRef]
77.
SchoemanSA, StewartCM, BoothRA, et al. Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study. BMJ. 2012Dec12;345:e8013. doi: 10.1136/bmj.e8013. PMID: 23236032. [PMC free article: PMC3520545] [PubMed: 23236032] [CrossRef]
78.
ScholesD, StergachisA, HeidrichFE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996May23;334(21):1362–6. doi: 10.1056/nejm199605233342103. PMID: 8614421. [PubMed: 8614421] [CrossRef]
79.
ShrierLA, DeanD, KleinE, et al. Limitations of screening tests for the detection of Chlamydia trachomatis in asymptomatic adolescent and young adult women. Am J Obstet Gynecol. 2004Mar;190(3):654–62. doi: 10.1016/j.ajog.2003.09.063. PMID: 15041995. [PubMed: 15041995] [CrossRef]
80.
StewartCM, SchoemanSA, BoothRA, et al. Assessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy study. BMJ. 2012Dec12;345:e8107. doi: 10.1136/bmj.e8107. PMID: 23236033. [PMC free article: PMC3520546] [PubMed: 23236033] [CrossRef]
81.
CherneskyMA, MartinDH, HookEW, et al. Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs. J Clin Microbiol. 2005Jan;43(1):127–31. doi: 10.1128/jcm.43.1.127-131.2005. PMID: 15634960. [PMC free article: PMC540117] [PubMed: 15634960] [CrossRef]
82.
GaydosCA, Van Der PolB, Jett-GoheenM, et al. Performance of the cepheid CT/NG xpert rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2013Jun;51(6):1666–72. doi: 10.1128/jcm.03461-12. PMID: 23467600. [PMC free article: PMC3716060] [PubMed: 23467600] [CrossRef]
83.
GotzHM, VeldhuijzenIK, HabbemaJD, et al. Prediction of Chlamydia trachomatis infection: application of a scoring rule to other populations. Sex Transm Dis. 2006Jun;33(6):374–80. doi: 10.1097/01.olq.0000194585.82456.51. PMID: 16505746. [PubMed: 16505746] [CrossRef]
84.
TaylorSN, LiesenfeldO, LillisRA, et al. Evaluation of the roche cobas(R) CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. Sex Transm Dis. 2012Jul;39(7):543–9. doi: 10.1097/OLQ.0b013e31824e26ff. PMID: 22706217. [PubMed: 22706217] [CrossRef]
85.
TaylorSN, Van Der PolB, LillisR, et al. Clinical evaluation of the BD probetec Chlamydia trachomatis qx amplified DNA assay on the BD viper system with XTR technology. Sex Transm Dis. 2011Jul;38(7):603–9. doi: 10.1097/OLQ.0b013e31820a94d2. PMID: 21301389. [PMC free article: PMC3763498] [PubMed: 21301389] [CrossRef]
86.
Van Der PolB, LiesenfeldO, WilliamsJA, et al. Performance of the cobas CT/NG test compared to the aptima AC2 and viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2012Jul;50(7):2244–9. doi: 10.1128/jcm.06481-11. PMID: 22518864. [PMC free article: PMC3405604] [PubMed: 22518864] [CrossRef]
87.
Van Der PolB, TaylorSN, LebarW, et al. Clinical evaluation of the BD probetec Neisseria gonorrhoeae qx amplified DNA assay on the BD viper system with XTR technology. Sex Transm Dis. 2012Feb;39(2):147–53. doi: 10.1097/OLQ.0b013e3182372fd8. PMID: 22249304. [PMC free article: PMC3725734] [PubMed: 22249304] [CrossRef]
88.
AndersenB, OstergaardL, MollerJK, et al. Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women: randomised study. BMJ. 1998Jan31;316(7128):350–1. doi: 10.1136/bmj.316.7128.350. PMID: 9487169. [PMC free article: PMC2665537] [PubMed: 9487169] [CrossRef]
89.
DingA, ChallenorR. Rectal Chlamydia in heterosexual women: more questions than answers. Int J STD AIDS. 2014Jul;25(8):587–92. doi: 10.1177/0956462413515637. PMID: 24352134. [PubMed: 24352134] [CrossRef]
90.
KwongJC, ChowEPF, StevensK, et al. Whole-genome sequencing reveals transmission of gonococcal antibiotic resistance among men who have sex with men: an observational study. Sex Transm Infect. 201803;94(2):151–7. doi: 10.1136/sextrans-2017-053287. PMID: 29247013. [PMC free article: PMC5870456] [PubMed: 29247013] [CrossRef]
91.
AlthausCL, TurnerKM, MercerCH, et al. Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling. Health Technol Assess. 2014Jan;18(2):1–100, vii–viii. doi: 10.3310/hta18020. PMID: 24411488. [PMC free article: PMC4780998] [PubMed: 24411488] [CrossRef]
92.
EstcourtCS, SutcliffeLJ, CopasA, et al. Developing and testing accelerated partner therapy for partner notification for people with genital Chlamydia trachomatis diagnosed in primary care: a pilot randomised controlled trial. Sexually Transmitted Infections. 2015Dec;91(8):548–54. doi: 10.1136/sextrans-2014-051994. PMID: 26019232. [PMC free article: PMC4680194] [PubMed: 26019232] [CrossRef]
93.
FerreiraA, YoungT, MathewsC, et al. Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database Syst Rev. 2013Oct3(10):Cd002843. doi: 10.1002/14651858.CD002843.pub2. PMID: 24092529. [PMC free article: PMC7138045] [PubMed: 24092529] [CrossRef]
94.
MohammedH, MitchellH, SileB, et al. Increase in Sexually Transmitted Infections among Men Who Have Sex with Men, England, 2014. Emerg Infect Dis. 2016Jan;22(1):88–91. doi: 10.3201/eid2201.151331. PMID: 26689861. [PMC free article: PMC4696713] [PubMed: 26689861] [CrossRef]
95.
UnemoM, ShaferWM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014Jul;27(3):587–613. doi: 10.1128/CMR.00010-14. PMID: 24982323. [PMC free article: PMC4135894] [PubMed: 24982323] [CrossRef]
96.
MarcusJL, BernsteinKT, KohnRP, et al. Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sex Transm Dis. 2011Oct;38(10):922–4. doi: 10.1097/OLQ.0b013e31822a2b2e. PMID: 21934565. [PubMed: 21934565] [CrossRef]
97.
Centers for Disease Control and Prevention. HIV and Transgender People. 2021. https://www​.cdc.gov/hiv​/group/gender/transgender/index.html. Accessed May 28, 2021.
98.
PitasiMA, KeraniRP, KohnR, et al. Chlamydia, Gonorrhea, and Human Immunodeficiency Virus Infection Among Transgender Women and Transgender Men Attending Clinics that Provide Sexually Transmitted Disease Services in Six US Cities: Results From the Sexually Transmitted Disease Surveillance Network. Sex Transm Dis. 2019Feb;46(2):112–7. doi: 10.1097/olq.0000000000000917. PMID: 30278030. [PubMed: 30278030] [CrossRef]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.6M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...